A CLINICAL RESEARCH ON "PERUMBADU"(MENORRHAGIA) WITH THE EVALUATION OF SIDDHA DRUG"KADHALIPOO RASAYANAM"

A CLINICAL STUDY ON "PERUMBADU"(MENORRHAGIA)WITH THE EVALUATION OF SIDDHA DRUG "KADHALIPOO RASAYANAM"

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/02/012118

Enrollment

Registered

2018-02-23

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- FEMALE PATIENTS WITH EXCESSIVE MENSTRUAL BLEEDING FOR 10 DAYS

Interventions

Intervention1: KADHALI POO RASAYANAM: DOSE 5 GM BD DURATION 7 DAYS ADJUVANT MILK Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: 1.EXCESSIVE MENSTRUATION 2.PROLONGED MENSTRUATION 3.PUBERTY MENORRHAGIA 4.PREMENOPAUSAL MENORRHAGIA 5.POLYCYSTIC OVARIES IN ULTRASOUND

Exclusion criteria

Exclusion criteria: 1.UTERINE FIBROIDS 2.FIBROID POLYP 3.ADENOMYOSIS 4.CHOCOLATE CYST 5.OVARIAN FEMINIZING TUMOURS 6.THROMOBOCYTOPENIC PURPURA COAGULOPATHY SEVERE ANAEMIA ( HYPOTHYROIDISM VULNEARABLE POPULATIONS SUCH AS HIV POSITIVE TB AFFECTED INDIVIDUALS DIABETES MELLITUS PATIENT HAVING IUCD ABORTION

Design outcomes

Primary

Measure	Time frame
PRIMARY OUTCOME IS MAINLY ASSESSED BY REDUCTION IN CLINICAL SYMPTOMS AND BY COMPARING THE FOLLOWING PARAMETERS BEFORE AND AFTER TREATMENT. 1.REDUCED AMOUNT OF BLOOD FLOW IS ASSESSED BY NUMBER OF SANITARY PADS USED BEFORE AND AFTER TREATMENT Timepoint: PRIMARY OUTCOME IS MAINLY ASSESSED BY REDUCTION IN CLINICAL SYMPTOMS AND BY COMPARING THE FOLLOWING PARAMETERS BEFORE AND AFTER TREATMENT. 1.REDUCED AMOUNT OF BLOOD FLOW IS ASSESSED BY NUMBER OF SANITARY PADS USED BEFORE AND AFTER TREATMENT	—

Measure

Time frame

PRIMARY OUTCOME IS MAINLY ASSESSED BY REDUCTION IN CLINICAL SYMPTOMS AND BY COMPARING THE FOLLOWING PARAMETERS BEFORE AND AFTER TREATMENT. 1.REDUCED AMOUNT OF BLOOD FLOW IS ASSESSED BY NUMBER OF SANITARY PADS USED BEFORE AND AFTER TREATMENT Timepoint: PRIMARY OUTCOME IS MAINLY ASSESSED BY REDUCTION IN CLINICAL SYMPTOMS AND BY COMPARING THE FOLLOWING PARAMETERS BEFORE AND AFTER TREATMENT. 1.REDUCED AMOUNT OF BLOOD FLOW IS ASSESSED BY NUMBER OF SANITARY PADS USED BEFORE AND AFTER TREATMENT

—

Secondary

Measure	Time frame
SECONDARY OUTCOME IS ASSESSED BY COMPARING THE SAFETY PARAMETERS BEFORE AND AFTER TREATMENTTimepoint: 7 DAYS	—

Countries

India

Contacts

Public ContactDR P PARTHIBHAN

GOVERNMENT SIDDHA MEDICAL COLLEGE

drkkanakavalli@gmail.com9444122865

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026